Loading clinical trials...
Loading clinical trials...
The goal of this study is to assess the safety and therapeutic potential of a single dose of avoralstat in adult participants with DME.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
BioCryst Pharmaceuticals
NCT07308639 · Neovascular Age-related Macular Degeneration (nAMD); Diabetic Macular Edema (DME); Retinal Vein Occlusion (RVO)
NCT07449936 · Diabetic Macular Edema, DME, and more
NCT07449923 · Diabetic Macular Edema, DME, and more
NCT06929143 · Neovascular Age-related Macular Degeneration (nAMD), Diabetic Macular Edema (DME)
NCT06116916 · Diabetic Macular Edema (DME)
Investigative Site 6
Sacramento, California
Investigative Site 7
Katy, Texas
Investigative Site 8
The Woodlands, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions